231 related articles for article (PubMed ID: 17611576)
1. A pathogenic role for IgE in autoimmunity: bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice.
Fairley JA; Burnett CT; Fu CL; Larson DL; Fleming MG; Giudice GJ
J Invest Dermatol; 2007 Nov; 127(11):2605-11. PubMed ID: 17611576
[TBL] [Abstract][Full Text] [Related]
2. Unraveling the significance of IgE autoantibodies in organ-specific autoimmunity: lessons learned from bullous pemphigoid.
Messingham KA; Holahan HM; Fairley JA
Immunol Res; 2014 Aug; 59(1-3):273-8. PubMed ID: 24845463
[TBL] [Abstract][Full Text] [Related]
3. IgE autoantibodies against the intracellular domain of BP180.
Dresow SK; Sitaru C; Recke A; Oostingh GJ; Zillikens D; Gibbs BF
Br J Dermatol; 2009 Feb; 160(2):429-32. PubMed ID: 18808416
[TBL] [Abstract][Full Text] [Related]
4. Role of IgE in bullous pemphigoid: a review and rationale for IgE directed therapies.
Messingham KN; Pietras TA; Fairley JA
G Ital Dermatol Venereol; 2012 Jun; 147(3):251-7. PubMed ID: 22648326
[TBL] [Abstract][Full Text] [Related]
5. Exploring mechanisms of IgE-mediated autoimmunity through the lens of bullous pemphigoid.
Messingham KN; Randall G; Fairley J
G Ital Dermatol Venereol; 2016 Apr; 151(2):186-97. PubMed ID: 26959553
[TBL] [Abstract][Full Text] [Related]
6. Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model.
Liu Z; Sui W; Zhao M; Li Z; Li N; Thresher R; Giudice GJ; Fairley JA; Sitaru C; Zillikens D; Ning G; Marinkovich MP; Diaz LA
J Autoimmun; 2008 Dec; 31(4):331-8. PubMed ID: 18922680
[TBL] [Abstract][Full Text] [Related]
7. Identification of a potential effector function for IgE autoantibodies in the organ-specific autoimmune disease bullous pemphigoid.
Dimson OG; Giudice GJ; Fu CL; Van den Bergh F; Warren SJ; Janson MM; Fairley JA
J Invest Dermatol; 2003 May; 120(5):784-8. PubMed ID: 12713582
[TBL] [Abstract][Full Text] [Related]
8. Levels of anti-BP180 NC16A IgE do not correlate with severity of disease in the early stages of bullous pemphigoid.
Bing L; Xiping Z; Li L; Jun P; Yi-Xia W; Min Y; Qing L; Qiu-Ning S; Hong-Zhong J; Ya-Gang Z
Arch Dermatol Res; 2015 Nov; 307(9):849-54. PubMed ID: 26404084
[TBL] [Abstract][Full Text] [Related]
9. Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid.
Fairley JA; Fu CL; Giudice GJ
J Invest Dermatol; 2005 Sep; 125(3):467-72. PubMed ID: 16117787
[TBL] [Abstract][Full Text] [Related]
10. FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid.
Messingham KN; Srikantha R; DeGueme AM; Fairley JA
J Immunol; 2011 Jul; 187(1):553-60. PubMed ID: 21646296
[TBL] [Abstract][Full Text] [Related]
11. In vivo analysis of IgE autoantibodies in bullous pemphigoid: a study of 100 cases.
Moriuchi R; Nishie W; Ujiie H; Natsuga K; Shimizu H
J Dermatol Sci; 2015 Apr; 78(1):21-5. PubMed ID: 25724363
[TBL] [Abstract][Full Text] [Related]
12. IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice.
Zone JJ; Taylor T; Hull C; Schmidt L; Meyer L
J Invest Dermatol; 2007 May; 127(5):1167-74. PubMed ID: 17235329
[TBL] [Abstract][Full Text] [Related]
13. What's new in bullous pemphigoid.
Ujiie H; Shibaki A; Nishie W; Shimizu H
J Dermatol; 2010 Mar; 37(3):194-204. PubMed ID: 20507382
[TBL] [Abstract][Full Text] [Related]
14. IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants.
Freire PC; Muñoz CH; Stingl G
Br J Dermatol; 2017 Dec; 177(6):1644-1653. PubMed ID: 28868796
[TBL] [Abstract][Full Text] [Related]
15. IgE autoantibodies and their association with the disease activity and phenotype in bullous pemphigoid: a systematic review.
Saniklidou AH; Tighe PJ; Fairclough LC; Todd I
Arch Dermatol Res; 2018 Jan; 310(1):11-28. PubMed ID: 29071428
[TBL] [Abstract][Full Text] [Related]
16. Human eosinophils express the high affinity IgE receptor, FcεRI, in bullous pemphigoid.
Messingham KN; Holahan HM; Frydman AS; Fullenkamp C; Srikantha R; Fairley JA
PLoS One; 2014; 9(9):e107725. PubMed ID: 25255430
[TBL] [Abstract][Full Text] [Related]
17. Granulocyte-derived elastase and gelatinase B are required for dermal-epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid.
Shimanovich I; Mihai S; Oostingh GJ; Ilenchuk TT; Bröcker EB; Opdenakker G; Zillikens D; Sitaru C
J Pathol; 2004 Dec; 204(5):519-27. PubMed ID: 15538734
[TBL] [Abstract][Full Text] [Related]
18. The Autoimmune Skin Disease Bullous Pemphigoid: The Role of Mast Cells in Autoantibody-Induced Tissue Injury.
Fang H; Zhang Y; Li N; Wang G; Liu Z
Front Immunol; 2018; 9():407. PubMed ID: 29545809
[TBL] [Abstract][Full Text] [Related]
19. Detection of IgG and IgE reactivity to BP180 using the ISAC® microarray system.
Pomponi D; Di Zenzo G; Zennaro D; Calabresi V; Eming R; Zuzzi S; Bernardi ML; Scala E; Mari A
Br J Dermatol; 2013 Jun; 168(6):1205-14. PubMed ID: 23252883
[TBL] [Abstract][Full Text] [Related]
20. The desmosome and hemidesmosome in cutaneous autoimmunity.
Lin MS; Mascaró JM; Liu Z; España A; Diaz LA
Clin Exp Immunol; 1997 Jan; 107 Suppl 1():9-15. PubMed ID: 9020929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
